UNICHEM LABORATORIES Financial Statement Analysis
|
||
The Revenues of UNICHEM LABORATORIES have decreased by -98.67% YoY .
The Earnings Per Share (EPS) of UNICHEM LABORATORIES has increased by Positive YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
UNICHEM LABORATORIES Last 5 Annual Financial Results
[BOM: 506690|NSE : UNICHEMLAB]
Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
---|---|---|---|---|---|
Revenues | ₹1,785 Cr | ₹134,302 Cr | ₹1,270 Cr | ₹1,235 Cr | ₹1,104 Cr |
Expenses | ₹1,698 Cr | ₹138,858 Cr | ₹1,197 Cr | ₹1,144 Cr | ₹1,155 Cr |
Operating Profit (Excl OI) | ₹87 Cr | ₹-4,556 Cr | ₹73 Cr | ₹91 Cr | ₹-51 Cr |
Other Income | ₹32 Cr | ₹3,852 Cr | ₹48 Cr | ₹50 Cr | ₹91 Cr |
Interest | ₹23 Cr | ₹1,731 Cr | ₹6.11 Cr | ₹5.12 Cr | ₹7.85 Cr |
Depreciation | ₹123 Cr | ₹11,344 Cr | ₹91 Cr | ₹84 Cr | ₹82 Cr |
Profit Before Tax | ₹-85 Cr | ₹-17,636 Cr | ₹22 Cr | ₹51 Cr | ₹-48 Cr |
Profit After Tax | ₹-94 Cr | ₹-20,223 Cr | ₹33 Cr | ₹34 Cr | ₹-60 Cr |
Consolidated Net Profit | ₹-94 Cr | ₹-20,223 Cr | ₹33 Cr | ₹34 Cr | ₹-60 Cr |
Earnings Per Share (Rs) | ₹19.53 | ₹-13.32 | ₹-28.72 | ₹4.70 | ₹4.88 |
PAT Margin (%) | 6.51 | -5.25 | -15.06 | 2.60 | 2.78 |
ROE(%) | 5.64 | -3.86 | -8.04 | 1.28 | 1.35 |
ROCE(%) | 6.34 | -2.31 | -5.60 | 1.00 | 2.11 |
Total Debt/Equity(x) | 0.18 | 0.09 | 0.12 | 0.13 | 0.04 |
Key Financials |
||
Market Cap | : | ₹ 4,157.5 Cr |
Revenue (TTM) | : | ₹ 2,028.9 Cr |
Net Profit(TTM) | : | ₹ 150.6 Cr |
EPS (TTM) | : | ₹ 21.4 |
P/E (TTM) | : | 27.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
UNICHEM LABORATORIES | -1.8% | -6.1% | 11.7% |
SUN PHARMACEUTICAL INDUSTRIES | -0.4% | -0.9% | 4.8% |
DIVIS LABORATORIES | -0.7% | 1.6% | 50.2% |
CIPLA | -1.7% | -1.1% | -2.3% |
TORRENT PHARMACEUTICALS | -1.1% | 1.6% | 13.7% |
DR REDDYS LABORATORIES | -4.3% | -8% | -4.4% |
MANKIND PHARMA | 6.8% | 8% | 20.9% |
ZYDUS LIFESCIENCES | -1.9% | 0.1% | -16.5% |
LUPIN | -4.3% | -6.4% | 4.6% |
UNICHEM LABORATORIES Revenues
[BOM: 506690|NSE : UNICHEMLAB]
Y-o-Y | -98.67 % |
5 Yr CAGR | 12.77 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹1,785 Cr | -98.67 | |
Mar2024 | ₹134,302 Cr | 10,476.38 | |
Mar2023 | ₹1,270 Cr | 2.81 | |
Mar2022 | ₹1,235 Cr | 11.91 | |
Mar2021 | ₹1,104 Cr | - |
UNICHEM LABORATORIES Operating Profit
[BOM: 506690|NSE : UNICHEMLAB]
Y-o-Y | Positive |
5 Yr CAGR | Positive |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹87 Cr | Positive | |
Mar2024 | ₹-4,556 Cr | Negative | |
Mar2023 | ₹73 Cr | -20.10 | |
Mar2022 | ₹91 Cr | Positive | |
Mar2021 | ₹-51 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | Positive |
5 Yr CAGR | Positive |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 4.87% | Positive | |
Mar2024 | -3.39% | Negative | |
Mar2023 | 5.73% | -22.36 | |
Mar2022 | 7.38% | Positive | |
Mar2021 | -4.6% | - |
UNICHEM LABORATORIES Profit After Tax
[BOM: 506690|NSE : UNICHEMLAB]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹-94 Cr | Negative | |
Mar2024 | ₹-20,223 Cr | Negative | |
Mar2023 | ₹33 Cr | -3.68 | |
Mar2022 | ₹34 Cr | Positive | |
Mar2021 | ₹-60 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Positive |
5 Yr CAGR | 23.70 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 6.51 % | Positive | |
Mar2024 | -5.25 % | Negative | |
Mar2023 | -15.06 % | Negative | |
Mar2022 | 2.6 % | -6.47 | |
Mar2021 | 2.78 % | - |
UNICHEM LABORATORIES Earnings Per Share (EPS)
[BOM: 506690|NSE : UNICHEMLAB]
Y-o-Y | Positive |
5 Yr CAGR | 41.44 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹20 | Positive | |
Mar2024 | ₹-13 | Negative | |
Mar2023 | ₹-29 | Negative | |
Mar2022 | ₹4.70 | -3.69 | |
Mar2021 | ₹4.88 | - |
UNICHEM LABORATORIES Return on Capital Employed (ROCE)
[BOM: 506690|NSE : UNICHEMLAB]
Y-o-Y | Positive |
5 Yr CAGR | 31.66 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 6.34% | Positive | |
Mar2024 | -2.31% | Negative | |
Mar2023 | -5.6% | Negative | |
Mar2022 | 1% | -52.61 | |
Mar2021 | 2.11% | - |
UNICHEM LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹590.6 |
Current MarketCap | : | ₹ 4,157.5 Cr |
Updated EOD on | : | Jul 11,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
UNICHEM LABORATORIES | -1.8% |
-6.1% |
11.7% |
SENSEX | -1.1% |
-0% |
3.2% |
UNICHEM LABORATORIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE SMALLCAP | -0.6% | 0.4% | 0.8% |
BSE HEALTHCARE | -1.3% | 0.7% | 16.5% |
You may also like the below Video Courses
FAQ about UNICHEM LABORATORIES Financials
How the annual revenues of UNICHEM LABORATORIES have changed ?
The Revenues of UNICHEM LABORATORIES have decreased by -98.67% YoY .
How the Earnings per Share (EPS) of UNICHEM LABORATORIES have changed?
The Earnings Per Share (EPS) of UNICHEM LABORATORIES has increased by Positive YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs